HomeResearch & Knowledgeback to HomeEntrepreneurshipback to Research & KnowledgeGeneration Jobless?back to Entrepreneurship

Book

Generation Jobless?

Turning the youth unemployment crisis into opportunity

By Peter Vogel

253 pages

Hardcover

Overview

Keep reading

Overview

Keep reading

Generation Jobless? uniquely explores the characteristics of both today’s and tomorrow’s youth and the causes of the youth unemployment crisis.

The book takes a global, multi-stakeholder perspective to showcase proven solutions to tackle the crisis. Featuring interviews and input from business leaders, policy makers, educators, entrepreneurs and the Next Generation itself, it offers a positive and constructive look at change by directing each group to become part of the solution and in particular youth to take on responsibility for themselves and their peers by turning into job creators rather than job seekers.

Contact

Research Information & Knowledge Hub for additional information on IMD publications

Hardcover

eBook

You can also buy the book on Barnes & Nobles, Book Depository, Orell Füssli and Routledge.

Publisher

Palgrave Macmillan

ISBN

9781137375933

Keep reading

Article

Five key insights from necessity entrepreneurs

There is another entrepreneurial world that is born not from opportunity but from necessity, and it has much to teach us.

Entrepreneurship Innovation

By Sophie Bacq

in I by IMD

Case Study

Oculis: Transforming ophthalmology a drop at a time

Start-up Venture Capital Entrepreneurship Strategy

By Benoit F. Leleux, Abdulaziz A. AlSayyari, Barbara Müller and Vladimir Novotny

Article

Global talent mobility - United States Of America

Global talent mobility is shifting as rising US costs, visa limits, and policy uncertainty push students and skilled workers to new destinations worldwide.

Talent Management

By Fabian Grimm and Francesco Farné

in I by IMD

Article

The career dilemma at year’s end - Stay or go?

Workers face tough choices in a cooling labour market as IMD experts explore the risks and rewards of quitting, from career growth to financial and flexibility concerns.

Talent Management

By José Caballero and Silke Mischke

in I by IMD

Article

Longevity: Three trends that redefine how we live and work

Three options for a world of longevity where people will routinely live in good health into their nineties.

Leadership Talent Management Work-life Balance

By Nele Dael and Alyson Meister

in I by IMD

Article

Tool or talent: How is your organization using AI?

AI has the potential to become a super-useful teammate, but CHROs must manage its deployment with care. Answer the questions below to check how employees feel about its adoption and watch out for three possible impacts on team dynamics.

Artificial Intelligence Talent Management

By Ginka Toegel

in I by IMD Brain Circuits

10 December 2025

Podcast

Zhike Lei & Marcus Schindler on exploration and purpose at Novo Nordisk

IMD’s Zhike Lei interviews former Novo Nordisk R&D head Marcus Schindler on balancing delivery and discovery, building AI-ready teams, and leading innovation up

Innovation Leadership Talent Management

By Zhike Lei

in I by IMD

Article

The End of Job Titles - AI - Skills-powered Strategies

Gloat’s Jeff Schwartz and Mike Worthington reveal how AI and skills-powered strategies are transforming talent management and workforce strategy.

Strategy Talent Management

in I by IMD

Article

CHROs: Think skills, not jobs, to realize radical productivity gains 

A skills-powered approach to talent management can boost agility, efficiency, and productivity, but transitioning to it is a complex undertaking. Ravin Jesuthasan explains how to get started and identifies the eight pillars that support a skills-p...

Talent Management Human Resources

By I by IMD

in I by IMD Brain Circuits

4 December 2025

Article

Tokio Marine Holdings - Future Proofing Leadership

Tokio Marine shows how a Japanese insurance group can build ambidextrous future leaders through immersive development. Five lessons to future-proof succession.

Talent Management

By Patrick Reinmoeller

in I by IMD

Oculis: Transforming ophthalmology a drop at a time

By Benoit F. Leleux Abdulaziz A. AlSayyari Barbara Müller and Vladimir Novotny
Case reference: IMD-2692 ©2025

Summary

For the team at Oculis, the announcement of the new USD 100 million fundraising could not have come at a more opportune moment. The biopharmaceutical startup was founded in 2017 to transform ophthalmology by developing not only original delivery mechanisms but also groundbreaking treatments for eye diseases like Diabetic Macular Edema (DME). Established by seasoned industry experts, Oculis aimed to replace invasive eye treatments with more accessible, patient-friendly solutions such as topical eye drops. The initial research conducted in a laboratory in Iceland led to a pipeline of drug candidates, now at various stages of clinical testing. The firm continued to ramp up thanks to successive rounds of financing from top investors and partners, totaling more than USD 500 million at the end of 2024. However, it also faced some dramatic events, including the sudden death in early 2024 of its CTO. The company continued to scale, strategically balancing clinical advancements with regulatory milestones. The recent secondary offering on Nasdaq would accelerate the clinical development pipeline, in particular its novel neuroprotective candidate Prisosegtor (OCS-05), OCS-01, a topical eye drop for DME, and OCS-02, a topical biologic eye drop candidate for dry eye disease. Oculis now grappled with a number of strategic decisions, with two questions in particular concerning the team. Should it rely mostly on outsourcing production to a contract development and manufacturing organization (CDMO) or develop its own in-house manufacturing capabilities? There were strong benefits and drawbacks to both approaches. It faced a related dilemma with its product pipeline. Should it continue to rely on its own R&D, as in the past, or should it consider acquiring technologies outside, through M&A activities?

Reference IMD-2692

Organization Oculis

Industry Healthcare, Pharmaceuticals

Available Languages English

Contact

Research Information & Knowledge Hub for additional information on IMD publications

Related topics

Start-up

Venture Capital

Entrepreneurship

Strategy

Browse all topics

Longevity: Three trends that redefine how we live and work

By Nele Dael and Alyson Meister
in I by IMD

Summary

Three options for a world of longevity where people will routinely live in good health into their nineties.

Contact

Research Information & Knowledge Hub for additional information on IMD publications

Related topics

Leadership

Talent Management

Work-life Balance

Browse all topics

Zhike Lei & Marcus Schindler on exploration and purpose at Novo Nordisk

By Zhike Lei
in I by IMD

Summary

IMD’s Zhike Lei interviews former Novo Nordisk R&D head Marcus Schindler on balancing delivery and discovery, building AI-ready teams, and leading innovation up

Contact

Research Information & Knowledge Hub for additional information on IMD publications

Related topics

Innovation

Leadership

Talent Management

Browse all topics